End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
284,000 KRW | +0.89% | -3.40% | -19.43% |
May. 16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
- Stock Market
- Equities
- A128940 Stock
- News Hanmi Pharm. Co., Ltd.